We use cookies for a better user experience. Read our Privacy Policy

I Agree

Drugs of Abuse Testing Market Outlook, 2019-2027

Drugs of Abuse Testing Market (Products - Analyzers (Immunoassays, Chromatographic Devices, and Breath Analyzers), Rapid Testing Devices (Urine Testing and Oral Fluid Testing), and Consumables (Fluid Collection Devices); Sample Type: Saliva, Breath, Urine, Blood, and Hair and Sweat; Testing Type - Pain Management Testing, Criminal Justice Testing, and Work Place Screening; End-user: Hospitals, Diagnostic laboratories, On-the-spot Testing, and Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027

Global Drugs of Abuse Testing Market: Overview

Rising consumption of illegal drugs is resulting into increase in the requirement for drug abuse tests. This is one of the prominent factors creating revenue-generating opportunities in the global drugs of abuse testing market, which is expected to register growth at a CAGR of 5.7% during the forecast period from 2019 to 2027, note analysts at Transparency Market Research (TMR). Hence, it is prognosticated to gain a valuation of US$ 7.6 Bn by 2027.

The study by TMR provides 360-degree analysis of factors shaping the growth of drugs of abuse testing market. Moreover, this report delivers exclusive study of growth drivers, restraints, challenges, R&D activities, key regions, and competition landscape of the market for drugs of abuse testing.

The researchers of report by TMR have segmented all data and analysis of the global drugs of abuse testing market based on many important facets such as sample type, testing type, end-user, and region.

In terms of sample type, the market for drugs of abuse testing is classified into breath, saliva, blood, hair & sweat, and urine. Based on testing type, the drugs of abuse testing market is divided into criminal justice testing, workplace testing, and pain management testing. On the basis of end-user, the classification of the market for drugs of abuse testing is performed into diagnostics laboratories, hospitals, forensic laboratories, and on-the-spot testing.

drugs of abuse testing market

To know the scope of our report Get a Sample on Drugs of Abuse Testing Market

Rising Abuse of Prescription Drugs and Increase in Use of Drug Abuse Testing among Private Employers Fuel Market Growth

In recent years, several nations across the globe including the U.S. are experiencing increased cases and death rates due to abuse of prescription drugs or nonmedical utilization of prescription drugs.

The National Institute of Drug Abuse (NIDA) states that approximately 52 million people have utilized prescription drugs for nonmedical reasons for minimum one time in their lifetime. Besides, youth populace from across the globe is seen increasing the use of several pain relievers such as OxyContin and Vicodin, which are considered abused prescription drugs. Due to incorrect prescription and addiction to prescription drugs, there is notable increase in comorbid illnesses among older population. Hence, continuous increase in the abuse of prescription drugs is increasing the sales of drugs of abuse testing products.

People consuming illicit drugs tend to be less productive at work, change their jobs frequently, and they frequently absent at workplaces. These factors can result into increased risks of workplace accidents. As a result, many organizations across the globe are emphasizing on regularly performing drugs of abuse tests. Hence, the demand for drug abuse testing by public and private employers is estimated to increase in the years to come.

Get a glimpse of the in-depth analysis through our Report Brochure

North America: Dominant Region for Drugs of Abuse Testing Industry

Europe, North America, Middle East and Africa, Asia Pacific, and Latin America are some of the key regions of the drugs of abuse testing market. Of them, North America is dominant region in the market.

The market is estimated to gain promising sales opportunities in North America in years to come owing to factors such as rise in consumption of illicit drugs and the increase in the availability of insurance plans intended for expensive diagnosis tests in the region.

The nature of the global drugs of abuse testing market is highly fragmented due to existence of several international level players. This scenario represents the highly intense level of competition in the market.

Companies in the drugs of abuse testing market are using different strategies such as acquisitions, collaborations, regulatory approvals, and new products launches. Moreover, several enterprises are increasing investments in R&D projects to develop advanced products. Such initiatives are projected to help in the expansion of the drugs of abuse testing market.

Some key players operating in the drugs of abuse testing market are Laboratory Corporation of America Holdings, Alere Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Siemens Healthineers, Drägerwerk AG & Co. KGaA, Shimadzu Corporation, and Express Diagnostics International Inc.

Expanding operations in future? To get the perfect launch ask for a custom report

The global drugs of abuse testing market has been segmented as below:

by Product Type

  • Analyzers
    • Immunoassays Analyzers
    • Chromatographic Devices
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
    • Fluid Collection Devices
    • Others

by Sample Type

  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat

by Testing Type

  • Pain Management Testing
  • Criminal Justice Testing
  • Workplace Screening

by End-user

  • Hospitals
  • Diagnostics Laboratories
  • On-the-spot Testing
  • Forensic Laboratories

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Drugs of Abuse Testing Market Outlook, 2019-2027

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of drugs of abuse testing market?

Drugs of Abuse Testing Market was valued at US$ 6 Bn in 2018 and is anticipated to reach at a US$ 7.6 Bn By 2027

What is the anticipated CAGR of the drugs of abuse testing market in the forecast period?

Drugs of Abuse Testing Market is anticipated to grow at a CAGR of 5.7% during the forecast period

What are the key driving factors for the growth of the drugs of abuse testing market?

Drugs of Abuse Testing Market is driven by increasing consumption of illicit drugs, thereby creating demand for drug abuse tests

Which is the rising prominent segment in the drugs of abuse testing market?

The analyzers segment dominated the global drugs of abuse testing market in 2018 and the trend is projected to continue during the forecast period

Who are the key players in the global drugs of abuse testing market?

Key players in the global drugs of abuse testing market include Alere Inc., Laboratory Corporation of America Holdings, Roche Diagnostics, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Siemens Healthineers, Express Diagnostics International Inc.

 

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drugs of Abuse Testing Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Market Overview

    4.3. Regulatory Scenario

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunities

        4.4.4. Trends

    4.5. Market Revenue Projections (US$ Mn)

    4.6. Market Outlook

    4.7. Porter’s Five Forces Analysis 

    4.8. Value Chain Analysis

    4.9. Technology Assessment 

    4.10. Global Demand and Supply Scenario 

5. Global Drugs of Abuse Testing Market Analysis and Forecast, by Product Type

    5.1. Introduction 

    5.2. Product Comparison Matrix 

    5.3. Market Revenue Share (%) and Attractiveness Analysis, by Product Type

    5.4. Market Size (US$ Mn) Forecast, by Product Type, 2017 - 2019

        5.4.1. Analyzers 

            5.4.1.1. Immunoassay Analyzers

            5.4.1.2. Chromatographic Devices

            5.4.1.3. Breath Analyzers

        5.4.2. Rapid Testing Devices

            5.4.2.1. Urine Testing Devices 

            5.4.2.2. Oral Fluid Testing Devices

        5.4.3. Consumables

            5.4.3.1. Fluid Collection Devices

            5.4.3.2. Others

6. Global Drugs of Abuse Testing Market Analysis and Forecast, by Sample Type

    6.1. Introduction 

    6.2. Market Revenue Share (%) and Attractiveness Analysis, by Sample Type 

    6.3. Market Size (US$ Mn) Forecast, by Sample Type, 2017 - 2019 

        6.3.1. Saliva

        6.3.2. Breath

        6.3.3. Urine

        6.3.4. Blood

        6.3.5. Hair & Sweat

7. Global Drugs of Abuse Testing Market Analysis and Forecast, by Testing Type

    7.1. Introduction 

    7.2. Market Revenue Share (%) and Attractiveness Analysis, by Testing Type 

    7.3. Market Size (US$ Mn) Forecast, by Testing Type, 2017 - 2019

        7.3.1. Pain Management Testing

        7.3.2. Criminal Justice Testing

        7.3.3. Workplace Screening

8. Global Drugs of Abuse Testing Market Analysis and Forecast, by End-user 

    8.1. Introduction 

    8.2. Market Revenue Share (%) and Attractiveness Analysis, by End-user 

    8.3. Market Size (US$ Mn) Forecast, by End-user, 2017 - 2019

        8.3.1. Hospitals

        8.3.2. Diagnostics Laboratories

        8.3.3. On-the-spot Testing

        8.3.4. Forensic Laboratories

9. Global Drugs of Abuse Testing Market Analysis and Forecast, by Region 

    9.1. Market Revenue Share (%) and Attractiveness Analysis, by Region 

    9.2. Market Size (US$ Mn) Forecast, by Region, 2017 - 2019 

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East and Africa

10. North America Drugs of Abuse Testing Market Analysis and Forecast

    10.1. Market Overview

        10.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    10.2. Market Value Share Analysis, by Product Type, 2018 and 2027 

        10.2.1. Analyzers 

            10.2.1.1. Immunoassay Analyzers

            10.2.1.2. Chromatographic Devices

            10.2.1.3. Breath Analyzers

        10.2.2. Rapid Testing Devices

            10.2.2.1. Urine Testing Devices 

            10.2.2.2. Oral Fluid Testing Devices

        10.2.3. Consumables

            10.2.3.1. Fluid Collection Devices

            10.2.3.2. Others 

    10.3. Market Value Share Analysis, by Sample Type, 2018 and 2027 

        10.3.1. Saliva

        10.3.2. Breath

        10.3.3. Urine

        10.3.4. Blood

        10.3.5. Hair & Sweat

    10.4. Market Value Share Analysis, by Testing Type, 2018 and 2027

        10.4.1. Pain Management 

        10.4.2. Criminal Justice Testing 

        10.4.3. Workplace Screening

    10.5. Market Value Share Analysis, by End-user, 2018 and 2027 

        10.5.1. Hospitals 

        10.5.2. Diagnostics Laboratories

        10.5.3. On-The-Spot Testing

        10.5.4. Forensic Laboratories

    10.6. Market Value Share Analysis, by Country, 2018 and 2027

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Size (US$ Mn) Forecast, 2017 - 2019

        10.7.1. By Product Type

        10.7.2. By Sample Type

        10.7.3. By Testing Type

        10.7.4. By End-user

        10.7.5. By Country

    10.8. Market Attractiveness Analysis, 2017 - 2019

        10.8.1. By Product Type

        10.8.2. By Sample Type

        10.8.3. By Testing Type

        10.8.4. By End-user

        10.8.5. By Country

11. Europe Drugs of Abuse Testing Market Analysis and Forecast

    11.1. Market Overview

        11.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    11.2. Market Value Share Analysis, by Product Type, 2018 and 2027 

        11.2.1. Analyzers 

            11.2.1.1. Immunoassay Analyzers

            11.2.1.2. Chromatographic Devices

            11.2.1.3. Breath Analyzers

        11.2.2. Rapid Testing Devices

            11.2.2.1. Urine Testing Devices 

            11.2.2.2. Oral Fluid Testing Devices

        11.2.3. Consumables

            11.2.3.1. Fluid Collection Devices

            11.2.3.2. Others 

    11.3. Market Value Share Analysis, by Sample Type, 2018 and 2027 

        11.3.1. Saliva

        11.3.2. Breath

        11.3.3. Urine

        11.3.4. Blood

        11.3.5. Hair & Sweat

    11.4. Market Value Share Analysis, by Testing Type, 2018 and 2027

        11.4.1. Pain Management 

        11.4.2. Criminal Justice Testing 

        11.4.3. Workplace Screening

    11.5. Market Value Share Analysis, by End-user, 2018 and 2027 

        11.5.1. Hospitals 

        11.5.2. Diagnostics Laboratories

        11.5.3. On-the-Spot Testing

        11.5.4. Forensic Laboratories

    11.6. Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

        11.6.1. U.K.

        11.6.2. France

        11.6.3. Germany

        11.6.4. Italy

        11.6.5. Spain

        11.6.6. Russia

        11.6.7. Rest of Europe

    11.7. Market Size (US$ Mn) Forecast, 2017 - 2019

        11.7.1. By Product Type

        11.7.2. By Sample Type

        11.7.3. By Testing Type

        11.7.4. By End-user

        11.7.5. By Country/Sub-region

    11.8. Market Attractiveness Analysis, 2017 - 2019

        11.8.1. By Product Type

        11.8.2. By Sample Type

        11.8.3. By Testing Type

        11.8.4. By End-user

12. Asia Pacific Drugs of Abuse Testing Market Analysis and Forecast

    12.1. Market Overview

        12.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    12.2. Market Value Share Analysis, by Product Type, 2018 and 2027 

        12.2.1. Analyzers 

            12.2.1.1. Immunoassay Analyzers

            12.2.1.2. Chromatographic Devices

            12.2.1.3. Breath Analyzers

        12.2.2. Rapid Testing Devices

            12.2.2.1. Urine Testing Devices 

            12.2.2.2. Oral Fluid Testing Devices

        12.2.3. Consumables

            12.2.3.1. Fluid Collection Devices

            12.2.3.2. Others 

    12.3. Market Value Share Analysis, by Sample Type, 2018 and 2027

        12.3.1. Saliva

        12.3.2. Breath

        12.3.3. Urine

        12.3.4. Blood

        12.3.5. Hair & Sweat

    12.4. Market Value Share Analysis, by Testing Type, 2018 and 2027 

        12.4.1. Pain Management 

        12.4.2. Criminal Justice Testing 

        12.4.3. Workplace Screening

    12.5. Market Value Share Analysis, by End-user, 2018 and 2027 

        12.5.1. Hospitals 

        12.5.2. Diagnostics Laboratories

        12.5.3. On-the-Spot Testing

        12.5.4. Forensic Laboratories

    12.6. Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

        12.6.1. Japan

        12.6.2. China

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Size (US$ Mn) Forecast, 2017 - 2019

        12.7.1. By Product Type

        12.7.2. By Sample Type

        12.7.3. By Testing Type

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

    12.8. Market Attractiveness Analysis, 2017 - 2019

        12.8.1. By Product Type

        12.8.2. By Sample Type

        12.8.3. By Testing Type

        12.8.4. By End-user

13. Latin America Drugs of Abuse Testing Market Analysis and Forecast

    13.1. Market Overview

        13.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    13.2. Market Value Share Analysis, by Product Type, 2018 and 2027

        13.2.1. Analyzers 

            13.2.1.1. Immunoassay Analyzers

            13.2.1.2. Chromatographic Devices

            13.2.1.3. Breath Analyzers

        13.2.2. Rapid Testing Devices

            13.2.2.1. Urine Testing Devices 

            13.2.2.2. Oral Fluid Testing Devices

        13.2.3. Consumables

            13.2.3.1. Fluid Collection Devices

            13.2.3.2. Others 

    13.3. Market Value Share Analysis, by Sample Type, 2018 and 2027 

        13.3.1. Saliva

        13.3.2. Breath

        13.3.3. Urine

        13.3.4. Blood

        13.3.5. Hair & Sweat

    13.4. Market Value Share Analysis, by Testing Type, 2018 and 2027 

        13.4.1. Pain Management 

        13.4.2. Criminal Justice Testing 

        13.4.3. Workplace Screening

    13.5. Market Value Share Analysis, by End-user, 2018 and 2027

        13.5.1. Hospitals 

        13.5.2. Diagnostics Laboratories

        13.5.3. On-the-Spot Testing

        13.5.4. Forensic Laboratories

    13.6. Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

        13.6.1. Mexico

        13.6.2. Brazil

        13.6.3. Rest of Latin America

    13.7. Market Size (US$ Mn) Forecast, 2017 - 2019

        13.7.1. By Product Type

        13.7.2. By Sample Type

        13.7.3. By Testing Type

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

    13.8. Market Attractiveness Analysis, 2017 - 2019

        13.8.1. By Product Type

        13.8.2. By Sample Type

        13.8.3. By Testing Type

14. Middle East & Africa Drugs of Abuse Testing Market Analysis and Forecast

    14.1. Market Overview

        14.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    14.2. Market Value Share Analysis, by Product Type, 2018 and 2027

        14.2.1. Analyzers 

            14.2.1.1. Immunoassay Analyzers

            14.2.1.2. Chromatographic Devices

            14.2.1.3. Breath Analyzers

        14.2.2. Rapid Testing Devices

            14.2.2.1. Urine Testing Devices 

            14.2.2.2. Oral Fluid Testing Devices

        14.2.3. Consumables

            14.2.3.1. Fluid Collection Devices

            14.2.3.2. Others 

    14.3. Market Value Share Analysis, by Sample Type, 2018 and 2027

        14.3.1. Saliva

        14.3.2. Breath

        14.3.3. Urine

        14.3.4. Blood

        14.3.5. Hair & Sweat

    14.4. Market Value Share Analysis, by Testing Type, 2018 and 2027

        14.4.1. Pain Management 

        14.4.2. Criminal Justice Testing 

        14.4.3. Workplace Screening

    14.5. Market Value Share Analysis, by End-user, 2018 and 2027

        14.5.1. Hospitals 

        14.5.2. Diagnostics Laboratories

        14.5.3. On-the-Spot Testing

        14.5.4. Forensic Laboratories

    14.6. Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

        14.6.1. GCC Countries 

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Market Size (US$ Mn) Forecast, 2019-2027

        14.7.1. By Product Type

        14.7.2. By Sample Type

        14.7.3. By Testing Type

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

    14.8. Market Attractiveness Analysis, 2017 - 2019 

        14.8.1. By Product Type

        14.8.2. By Sample Type

        14.8.3. By Testing Type

        14.8.4. By End-user

15. Competition Landscape

    15.1. Market Player - Competition Matrix 

    15.2. Market Share Analysis, by Company (2018)

    15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)

        15.3.1. F. Hoffmann-La Roche Ltd.

            15.3.1.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2.  Financial Overview

            15.3.1.3.  Product Portfolio

            15.3.1.4.  SWOT Analysis

            15.3.1.5.  Strategic Overview

        15.3.2. Siemens Healthineers (Siemens AG)

            15.3.2.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2.  Financial Overview

            15.3.2.3.  Product Portfolio

            15.3.2.4.  SWOT Analysis

            15.3.2.5.  Strategic Overview

        15.3.3. Thermo Fisher Scientific, Inc.

            15.3.3.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2.  Financial Overview

            15.3.3.3.  Product Portfolio

            15.3.3.4.  SWOT Analysis

            15.3.3.5.  Strategic Overview

        15.3.4. Abbott

            15.3.4.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2.  Financial Overview

            15.3.4.3.  Product Portfolio

            15.3.4.4.  SWOT Analysis

            15.3.4.5.  Strategic Overview

        15.3.5. Shimadzu Corporation

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2.  Financial Overview

            15.3.5.3.  Product Portfolio

            15.3.5.4.  SWOT Analysis 

            15.3.5.5.  Strategic Overview

        15.3.6. Laboratory Corporation of America Holdings

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2.  Financial Overview

            15.3.6.3.  Product Portfolio

            15.3.6.4.  SWOT Analysis 

            15.3.6.5.  Strategic Overview

        15.3.7. Danaher 

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. SWOT Analysis

            15.3.7.5. Strategic Overview

        15.3.8. Drägerwerk AG & Co. KGaA

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2.  Financial Overview

            15.3.8.3.  Product Portfolio

            15.3.8.4.  SWOT Analysis 

            15.3.8.5.  Strategic Overview

        15.3.9. Express Diagnostics International, Inc.

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2.  Financial Overview

            15.3.9.3.  Product Portfolio

            15.3.9.4. SWOT Analysis 

            15.3.9.5. Strategic Overview

 

List of Table

Table 1: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027 

Table 2: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027

Table 3: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027

Table 4: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027

Table 5: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 6: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027 

Table 7: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027

Table 8: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027

Table 9: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027

Table 10: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 11: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027 

Table 12: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027

Table 13: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027

Table 14: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027

Table 15: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 16: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027 

Table 17: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027

Table 18: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027

Table 19: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027

Table 20: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027 

Table 22: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027

Table 23: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027

Table 24: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027

Table 25: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2017 – 2027

Table 26: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027 

Table 27: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027

Table 28: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027

Table 29: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027

Table 30: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

 

List of Figure

Figure 1 Figure 01: Global Drugs of Abuse Testing Market Size Value (US$ Mn) Forecast, 2017–2027

Figure 2 Figure 02: Global Drugs of Abuse Testing Market Value Share (%), by Product Type (2017)

Figure 3 Figure 03: Global Drugs of Abuse Testing Market Value Share (%), by Sample Type (2017)

Figure 4 Figure 04: Global Drugs of Abuse Testing Market Value Share (%), by Testing Type (2017)

Figure 5 Figure 05: Global Drugs of Abuse Testing Market Value Share (%), by End-user (2017)

Figure 6 Figure 06: Global Drugs of Abuse Testing Market Value Share (%), by Region (2017)

Figure 7 Figure 07: Global Drugs of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 8 Figure 08: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018–2026

Figure 9 Figure 09: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2017–2027

Figure 10 Figure 10: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Rapid Testing Devices, 2017–2027

Figure 11 Figure 11: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2017–2027

Figure 12 Figure 12: Global Drugs of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 13 Figure 13: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027

Figure 14 Figure 14: Global Drugs of Abuse Testing Sample Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Saliva 2017–2027

Figure 15 Figure 15: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breath, 2017–2027

Figure 16: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urine, 2017–2027

Figure 17: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood, 2017–2027

Figure 18: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hair & Sweat 2017–2027

Figure 19: Global Drugs of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027

Figure 20: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027

Figure 21: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pain Management Testing, 2017–2027

Figure 22: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Criminal Justice Testing, 2017–2027

Figure 23: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Workplace Screening, 2017–2027

Figure 24: Global Drugs of Abuse Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 25: Global Drugs of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027

Figure 26: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 27: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027

Figure 28: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by On-the-Spot Testing, 2017–2027

Figure 29: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Forensic Laboratories, 2017–2027

Figure 30: Global Drugs of Abuse Testing Market Value Share Analysis, by Region, 2018 and 2027

Figure 31: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Region, 2019-2027

Figure 32: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 33: North America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027

Figure 34: North America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 35: North America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 36: North America Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027

Figure 37: North America Drug of Abuse Testing Market Value Share Analysis, by End Users, 2018 and 2027

Figure 38: North America Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 39: North America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027

Figure 40: North America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027

Figure 41: North America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027

Figure 42: North America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027

Figure 43: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 44: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027

Figure 45: Europe Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 46: Europe Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 47: Europe Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027

Figure 48: Europe Drug of Abuse Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 49: Europe Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 50: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027

Figure 51: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027

Figure 52: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027

Figure 53: Europe Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027

Figure 54: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 55: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027

Figure 56: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 57: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 58: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027

Figure 59: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 60: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 61: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027

Figure 62: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027

Figure 63: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027

Figure 64: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027

Figure 65: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 66: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027

Figure 67: Latin America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 68: Latin America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 69: Latin America Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027

Figure 70: Latin America Drug of Abuse Testing Market Value Share Analysis, by End Users, 2018 and 2027

Figure 71: Latin America Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 72: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027

Figure 73: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027

Figure 74: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027

Figure 75: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027

Figure 76: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 77: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027

Figure 78: MEA Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 79: MEA Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027

Figure 80: MEA Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027

Figure 81: MEA Drug of Abuse Testing Market Value Share Analysis, by End-user, 2018 and 2027

Figure 82: MEA Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 83: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027

Figure 84: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027

Figure 85: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027

Figure 86: MEA Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027

Figure 87: Global Drugs of Abuse Testing Market Share, by Company, 2018

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

262

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved